Biogenix Pharma Private Limited
About Biogenix Pharma Private Limited
Data last updated:
Biogenix Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 12 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2015PTC100913.
The company has an authorised share capital of ₹7 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Somasundaram Prem Anand and Sumathy Sachidanandan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R – 72 Maraimalai Adigal Street Mmda Colony Arumbakkam, Chennai, Tamil Nadu, India – 600106.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.72 Lakh, a growth of 113% compared to the previous year. For the same year it recorded a net profit of ₹38,199 (net margin 3.3%) and EBITDA of ₹3.3 Lakh (EBITDA margin 28.2%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years and 29% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Biogenix Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressR – 72 Maraimalai Adigal Street Mmda Colony Arumbakkam, Chennai, Tamil Nadu, India – 600106
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Biogenix Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biogenix Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Biogenix Pharma Private Limited, buy the company report.
Financials of Biogenix Pharma Private Limited
FY 2025 filings availableBiogenix Pharma Private Limited reported revenue of ₹11.72 Lakh (up 113% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 113% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38,199 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.2% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biogenix Pharma Private Limited, buy the company report.
Board of directors of Biogenix Pharma Private Limited
Biogenix Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Somasundaram Prem Anand | Director | 12 Jun 2015 | 11 Years 4 Months | Current |
| Sumathy Sachidanandan | Director | 04 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Biogenix Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anuseva Health Care Private Limited | ₹11.79 Lakh (FY 2019) | 47.0% | Chennai, Tamil Nadu, India | |||
| Trawello Healthcare Services Private Limited | ₹11.77 Lakh (FY 2024) | 18.0% | Bangalore, Karnataka, India | |||
| Shri R N Pandit Memorial Healthcare Private Limited | ₹11.75 Lakh (FY 2024) | Ghaziabad, Uttar Pradesh, India | ||||
| Biogenix Pharma Private Limitedthis company | ₹11.72 Lakh (FY 2024) | ₹38,199 | 3.3% | 113.0% | Chennai, Tamil Nadu, India | |
| Safe Drugs Health Solutions Private Limited | ₹11.63 Lakh (FY 2023) | 34126.0% | Miryalguda, Telangana, India |
To see the full peer comparison of Biogenix Pharma Private Limited, buy the company report.
Auditor
Biogenix Pharma Private Limited is audited by ARASU & ARUNACHALAM for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARASU & ARUNACHALAM | FY 2017 | 000210S |
Shareholding
The shareholding of Biogenix Pharma Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Biogenix Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biogenix Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biogenix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Biogenix Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Biogenix Pharma Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Ravikumar ceased to be Director on 04 Jan 2019.
Frequently asked questions
Biogenix Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 12 June 2015 (11+ years old) and is registered under CIN U74999TN2015PTC100913.
Biogenix Pharma has 2 current directors:
- Somasundaram Prem Anand - Director
- Sumathy Sachidanandan - Director
The latest financial statements of Biogenix Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Biogenix Pharma is U74999TN2015PTC100913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biogenix Pharma was incorporated on 12 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Biogenix Pharma by revenue are Anuseva Health Care Private Limited, Trawello Healthcare Services Private Limited, Shri R N Pandit Memorial Healthcare Private Limited, Safe Drugs Health Solutions Private Limited, all in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities).
Ravikumar ceased to be Director on 04 Jan 2019. Sumathy Sachidanandan was appointed as Director on 04 Sep 2018. Somasundaram Prem Anand was appointed as Director on 12 Jun 2015.
The registered office of Biogenix Pharma is at R – 72 Maraimalai Adigal Street Mmda Colony Arumbakkam, Chennai, Tamil Nadu, India – 600106.
Biogenix Pharma operates in the healthcare industry, in the preventive health services segment.
The compliance status of Biogenix Pharma is active non-compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.
Biogenix Pharma can be reached at its registered office: R – 72 Maraimalai Adigal Street Mmda Colony Arumbakkam, Chennai, Tamil Nadu, India – 600106.